Start
Features
Free trial / FAQ

Researchers
Physicians
Pharmacists
Ecotrophologists
Product Managers
in Health Industries

Loading…

Medical Research Finder

Legal Notice
Privacy
Terms of Use

meRfi® Microbiome - The Digital Gut Microbiome Reference (incl. AI Chat)
Prebiotics, Probiotics, FMT / Manipulators of the Intestinal Microbiota

AuthorsReferences (Sources)

meRfi® AI Chat

NCT07421947 - CAD-Microbiome - Fecal Microbiota Transplantation (FMT) & Type 2 diabetes and stable coronary artery disease (CAD)

Welcome to meRfi Microbiome!

Please register to continue your trial period!

meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

(Login)

Navigation

Study overview

NCT07421947 - CAD-Microbiome - Fecal Microbiota Transplantation (FMT) & Type 2 diabetes and stable coronary artery disease (CAD) is a clinical basis science trial to study Fecal Microbiota Transplantation (FMT) in patients with type 2 diabetes and stable coronary artery disease (CAD).

Primary outcome measures

Change from baseline to 6 months in gut microbiome composition

Results

The trial has not started recruiting participants as of February 2026

…

AI Chat

7/1/2026

Chat with our artificial intelligence:

Start chat!